For the roughly one-third of adults with acute low back pain who are at elevated risk of developing a chronic, disabling condition, finding an early intervention that actually halts that progression would be transformative. The PACBACK trial is one of the most rigorously designed attempts yet to answer that question, and its findings may force a recalibration of clinical assumptions that have guided chiropractic and physical therapy practice for decades.
The trial enrolled adults with acute or subacute low back pain at moderate-to-high chronicity risk across two academic research centers, randomizing them across four arms over eight weeks: spinal manipulation therapy alone, clinician-supported biopsychosocial self-management alone, a combination of both, and guideline-based medical care as a control. The primary outcome was mean low back pain impact score on the NIH Task Force scale — ranging from 8 (best) to 50 (worst) — assessed between 10 and 12 months post-enrollment. Responder analyses tracked the proportion of participants achieving at least 50% symptom reduction, with a 30% reduction defined as the minimal clinically important difference.
This is a consequential finding for practitioners and patients alike. Spinal manipulation is among the most commonly recommended non-pharmacological treatments for low back pain, and its early application in high-risk patients has been theorized to interrupt the central sensitization and fear-avoidance pathways that drive chronicity. That this well-powered, factorial RCT conducted over a multi-year period at two universities found no meaningful advantage over guideline-based medical care suggests either that the intervention window for manipulation is narrower than assumed or that biopsychosocial risk factors are less modifiable by hands-on therapy than hoped. The self-management arm adds a nuanced layer: supported behavioral approaches also failed to clearly outperform usual care, challenging the broader premise of early intensive intervention for at-risk patients. Clinicians should treat these results as grounds for recalibrating referral patterns, while researchers should investigate whether specific subgroups — by pain phenotype or psychosocial profile — respond differently.